Education around access to innovative therapies in dermatology.
2026 · 1st Quarter (Jan 1 - Mar 31)
INCYTE CORPORATION
Filed by W STRATEGIES, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 18, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- W STRATEGIES, LLC
- Client
- INCYTE CORPORATION
- Filing UUID
- 5442beda-ef83-4855-ac74-94aaca6cf92d
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicaid Drug Rebate program rule. Public Law 119-21: One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act. Issues related to drug pricing.
Literal federal measure citations: H.R.946
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.